Impact of dendritic cell vaccines added to neoadjuvant CT on pathological complete responses in early breast cancer patients according to PD-L1 expression.

Authors

null

Ignacio Ortego

Clínica U. Navarra, Pamplona, Spain

Ignacio Ortego , Angel María Vizcay , Susana De La Cruz , Belén Pérez-Solans , Sandra Rubio , Javier Blanco , Miguel A. Idoate , Laura Hato , Susana Inoges Sancho , Ascension Lopez Diaz de Cerio , Salvador Martin-Algarra , Marta Santisteban

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Clinical Trial Registration Number

NCT01431196

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 585)

DOI

10.1200/JCO.2021.39.15_suppl.585

Abstract #

585

Poster Bd #

Online Only

Abstract Disclosures